These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 12750120

  • 1. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
    Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I.
    Arterioscler Thromb Vasc Biol; 2003 Jul 01; 23(7):1262-8. PubMed ID: 12750120
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
    He G, Andersen O, Haugaard SB, Lihn AS, Pedersen SB, Madsbad S, Richelsen B.
    Eur J Clin Invest; 2005 Sep 01; 35(9):583-90. PubMed ID: 16128865
    [Abstract] [Full Text] [Related]

  • 3. Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome.
    de Larrañaga G, Wingeyer SP, Graffigna M, Belli S, Bendezú K, Alvarez S, Levalle O, Fainboim H.
    Clin Appl Thromb Hemost; 2008 Jul 01; 14(3):319-24. PubMed ID: 18160600
    [Abstract] [Full Text] [Related]

  • 4. Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice.
    Oishi K, Ohkura N, Matsuda J, Ishida N.
    Thromb Haemost; 2007 Oct 01; 98(4):864-70. PubMed ID: 17938813
    [Abstract] [Full Text] [Related]

  • 5. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE, Ermetici F, Cereda E, Coman C, Locati M, Morricone L, Corsi MM, Ambrosi B.
    Nutr Metab Cardiovasc Dis; 2008 Oct 01; 18(8):523-30. PubMed ID: 18083357
    [Abstract] [Full Text] [Related]

  • 6. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
    He G, Pedersen SB, Bruun JM, Lihn AS, Jensen PF, Richelsen B.
    Horm Metab Res; 2003 Mar 01; 35(3):178-82. PubMed ID: 12734779
    [Abstract] [Full Text] [Related]

  • 7. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
    Raju J, Bird RP.
    Int J Obes (Lond); 2006 Aug 01; 30(8):1298-307. PubMed ID: 16477270
    [Abstract] [Full Text] [Related]

  • 8. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C.
    Diabetes; 2006 Aug 01; 55(8):2159-70. PubMed ID: 16873678
    [Abstract] [Full Text] [Related]

  • 9. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab.
    Di Rocco P, Manco M, Rosa G, Greco AV, Mingrone G.
    Obes Res; 2004 Apr 01; 12(4):734-9. PubMed ID: 15090644
    [Abstract] [Full Text] [Related]

  • 10. The fat mouse: a powerful genetic model to study elevated plasminogen activator inhibitor 1 in obesity/NIDDM.
    Samad F, Loskutoff DJ.
    Thromb Haemost; 1997 Jul 01; 78(1):652-5. PubMed ID: 9198233
    [Abstract] [Full Text] [Related]

  • 11. Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity.
    Bertola A, Deveaux V, Bonnafous S, Rousseau D, Anty R, Wakkach A, Dahman M, Tordjman J, Clément K, McQuaid SE, Frayn KN, Huet PM, Gugenheim J, Lotersztajn S, Le Marchand-Brustel Y, Tran A, Gual P.
    Diabetes; 2009 Jan 01; 58(1):125-33. PubMed ID: 18952835
    [Abstract] [Full Text] [Related]

  • 12. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
    Mavri A, Alessi MC, Bastelica D, Geel-Georgelin O, Fina F, Sentocnik JT, Stegnar M, Juhan-Vague I.
    Diabetologia; 2001 Nov 01; 44(11):2025-31. PubMed ID: 11719834
    [Abstract] [Full Text] [Related]

  • 13. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
    Begriche K, Lettéron P, Abbey-Toby A, Vadrot N, Robin MA, Bado A, Pessayre D, Fromenty B.
    Am J Physiol Endocrinol Metab; 2008 May 01; 294(5):E939-51. PubMed ID: 18349116
    [Abstract] [Full Text] [Related]

  • 14. Expression of TNF-alpha protein in omental and subcutaneous adipose tissue in obesity.
    Cao YL, Hu CZ, Meng X, Wang DF, Zhang J.
    Diabetes Res Clin Pract; 2008 Feb 01; 79(2):214-9. PubMed ID: 17935818
    [Abstract] [Full Text] [Related]

  • 15. Correlation between omental TNF-alpha protein and plasma PAI-1 in obesity subjects.
    Cao YL, Wang YX, Wang DF, Meng X, Zhang J.
    Int J Cardiol; 2008 Aug 29; 128(3):399-405. PubMed ID: 17698217
    [Abstract] [Full Text] [Related]

  • 16. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.
    Kinik ST, Ozbek N, Yuce M, Yazici AC, Verdi H, Ataç FB.
    Thromb Haemost; 2008 Feb 29; 99(2):352-6. PubMed ID: 18278185
    [Abstract] [Full Text] [Related]

  • 17. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
    Yki-Järvinen H, Sutinen J, Silveira A, Korsheninnikova E, Fisher RM, Kannisto K, Ehrenborg E, Eriksson P, Hamsten A.
    Arterioscler Thromb Vasc Biol; 2003 Apr 01; 23(4):688-94. PubMed ID: 12615670
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
    Takeshita Y, Takamura T, Hamaguchi E, Shimizu A, Ota T, Sakurai M, Kaneko S.
    Metabolism; 2006 Nov 01; 55(11):1464-72. PubMed ID: 17046548
    [Abstract] [Full Text] [Related]

  • 19. Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals.
    Eriksson P, Van Harmelen V, Hoffstedt J, Lundquist P, Vidal H, Stemme V, Hamsten A, Arner P, Reynisdottir S.
    Thromb Haemost; 2000 Apr 01; 83(4):545-8. PubMed ID: 10780314
    [Abstract] [Full Text] [Related]

  • 20. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.
    Crespo J, Cayón A, Fernández-Gil P, Hernández-Guerra M, Mayorga M, Domínguez-Díez A, Fernández-Escalante JC, Pons-Romero F.
    Hepatology; 2001 Dec 01; 34(6):1158-63. PubMed ID: 11732005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.